Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC gets NAD case

This article was originally published in The Tan Sheet

Executive Summary

Advertising for PBM Products' Ultra Bright Beginnings infant formula will be referred to FDA and FTC since the company declined to participate in a NAD review, the National Advertising Division says March 24. The Council of Better Business Bureaus group requested substantiation for PBM's comparative superiority claims including "the highest DHA at a low price" and "more DHA than any brand." PBM also was asked to provide substantiation for implied claims that babies fed Bright Beginnings "will be smarter than babies fed with other formulas," NAD states...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS099217

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel